Periprocedural Myocardial Infarction: A Review Article

Percutaneous coronary intervention (PCI) is linked to a number of complications, including periprocedural myocardial infarction (PPMI), which is defined as an increase in creatine kinase-MB (CK-MB) levels of >3 times the upper limit of the normal range in at least two blood samples with a normal baseline value, prolonged ischemia as evidenced by persistent chest pain (more than 20 minutes), and new pathological Q waves on the electrocardiogram (ECG). Periprocedural myocardial infarction occurred in roughly 6-7% of patients who had percutaneous coronary intervention (PCI) and was linked to poor outcomes, according to epidemiology. As a result, identifying the potential factors for detecting, preventing, and managing this incident is critical.